DYNE THERAPEUTICS

What this means for you

Not registered yet, but its 08 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98397757

Mark type

Stylized text

Filed

08 Feb 2024

Published for opposition

15 Oct 2024

Attorney of record

Christina M. Licursi

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparations for treating metabolic diseases or disorders; pharmaceutical preparations for treating central nervous system diseases or disorders
• Class 042 — Scientific and technological services: Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders

Owner

• Dyne Therapeutics, Inc., Waltham, MA, US
• Dyne Therapeutics, Inc., Waltham, MA, US

Prior registrations

• Registration 7100101
• Registration 7157817

Prosecution history

• 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 05 Mar 2026 — SOU EXTENSION 3 GRANTED
• 05 Mar 2026 — SOU EXTENSION 3 FILED
• 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
• 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 13 Nov 2025 — SOU EXTENSION 2 GRANTED
• 13 Nov 2025 — SOU EXTENSION 2 FILED
• 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
• 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 27 May 2025 — SOU EXTENSION 1 GRANTED
• 27 May 2025 — SOU EXTENSION 1 FILED
• 27 May 2025 — SOU TEAS EXTENSION RECEIVED
• 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 15 Oct 2024 — PUBLISHED FOR OPPOSITION